1-3 of 3
Marc Fila
Close
Sort by
Journal Articles

Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study

Clinical Trials & Observations
Fadi Fakhouri, Marc Fila, Aurélie Hummel, David Ribes, Anne-Laure Sellier-Leclerc, Simon Ville, Claire Pouteil-Noble, Jean-Philippe Coindre, Moglie Le Quintrec, Eric Rondeau, Olivia Boyer, François Provôt, Djamal Djeddi, William Hanf, Yahsou Delmas, Ferielle Louillet, Annie Lahoche, Guillaume Favre, Valérie Châtelet, Emma Allain Launay, Claire Presne, Ariane Zaloszyc, Sophie Caillard, Stéphane Bally, Quentin Raimbourg, Leïla Tricot, Christiane Mousson, Aurélie Le Thuaut, Chantal Loirat, Véronique Frémeaux-Bacchi
Journal: Blood
Blood (2021) 137 (18): 2438–2449.
https://doi.org/10.1182/blood.2020009280
Published: 2021
Includes: Supplemental data
Journal Articles

Eculizumab Inhibits Thrombotic Microangiopathy and Improves Renal Function in Pediatric Patients with Atypical Hemolytic Uremic Syndrome: 1-Year Update

Laurence A. Greenbaum, MDPhD, Marc Fila, MD PhD, Gianluigi Ardissino, MD PhD, Samhar I. Al-Akash, MD, Jonathan H Evans, MD, Kenneth Lieberman, MD, Silvio Maringhini, MD, Lars Pape, MD, Lesley Rees, MD FRCPCH, Nicole C.A.J. van de Kar, MD PhD, Johan Vande Walle, MD PhD, Masayo Ogawa, MD FAAP, Camille L. Bedrosian, MD, Christoph Licht, MD FRCP(C), FASN
Journal: Blood
Blood (2014) 124 (21): 4986.
https://doi.org/10.1182/blood.V124.21.4986.4986
Published: 2014
Journal Articles

Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function In Pediatric Patients (Pts) With Atypical Hemolytic Uremic Syndrome (aHUS)

Larry Greenbaum, MD, Marc Fila, Gianluigi Ardissino, Samhar Al-Akash, Jonathan Evans, Paul Henning, Kenneth Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, Nicole Kar, Johan Vande Walle, Masayo Ogawa, MD, FAAP, Camille L. Bedrosian, MD, Christoph Licht, MD
Journal: Blood
Blood (2013) 122 (21): 2191.
https://doi.org/10.1182/blood.V122.21.2191.2191
Published: 2013